Repeating BE study [Regulatives / Guidelines]

posted by Ram14 – India, 2014-12-25 19:24 (4205 d 14:51 ago) – Posting: # 14174
Views: 6,579

Hi All,

Question regarding the USFDA guideline for repeating a BE study.

The study is a normal two-way crossover bioequivalence study. The study failed because the molecule degraded during bio-analysis and long-term stability was not proven. Because the Test product is from same exhibit batch a repeat study is demanded by sponsor.

On what grounds can the study be repeated, or, what is the justification to repeat the study, such that it is acceptable by the FDA regulatory.

Thank you
Ram

Complete thread:

UA Flag
Activity
 Admin contact
23,656 posts in 4,994 threads, 1,571 registered users;
270 visitors (0 registered, 270 guests [including 17 identified bots]).
Forum time: 11:16 CEST (Europe/Vienna)

Try to learn something about everything
and everything about something.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5